article thumbnail

Certain hormone replacement therapy tablets linked to increased heart disease and blood clot risk

Medical Xpress - Cardiology

Certain hormone replacement therapy (HRT) tablets containing both estrogen and progestogen are associated with a higher risk of heart disease and rare but serious blood clots known as venous thromboembolism (VTE) in women around the age of menopause, finds a study from Sweden published in The BMJ today.

article thumbnail

Researchers explore whether gut microbes cause some COVID-19 patients to have higher blood clot risk

Medical Xpress - Cardiology

A gut microbial metabolite called 2-methylbutyrylcarnitine (2MBC) plays a role in exacerbating thrombosis—the formation of blood clots—researchers report February 23 in the journal Cell Metabolism.

article thumbnail

How Can IVC Filters Help Prevent Blood Clots?

CTVS

It’s hard to believe that every six minutes someone dies from a blood clot here in the United States. Blood clots are gel-like masses that form inside your arteries or veins anywhere in the body.

article thumbnail

Patients taking edoxoban after heart valve surgery had lower risk of stroke, blood clots

American Heart News - Heart News

Research Highlights: Edoxaban, a medication taken orally to prevent blood clots from forming, was found to be as effective and safe for stroke and blood clot prevention in patients after heart valve replacement surgery as warfarin, the current.

article thumbnail

COVID Vax and Blood Clots; Cancer Rise in Young Adults; Corpse-Abuse Charge Dropped

Med Page Today

(MedPage Today) -- Note that some links may require registration or subscription. In observance of Martin Luther King Day, Morning Break will not be published January 15 and will resume Tuesday January 16. Last year's COVID-19 booster reduced.

article thumbnail

Statins found to reduce risk of blood clots associated with menopausal hormone therapy

Medical Xpress - Cardiology

Researchers at the University of Texas Medical Branch, Galveston, have provided substantial evidence supporting the potential role of statins in mitigating venous thromboembolism (VTE) risk associated with hormone therapy in postmenopausal women, possibly reshaping the risk-benefit considerations for this population.

article thumbnail

FDA guidelines overlooked for common blood clot device: 5 notes

Becker's Hospital Review - Cardiology

Designed to temporarily prevent blood clots from traveling to the lungs, approximately 85% of inferior vena cava filters inserted over an eight-year period were not removed, according to a study published Nov. 6 in JAMA.